R. Don Elsey, CFO at Emergent BioSolutions Inc. (EBS), sold 9,334 shares at $17.80 ($172K) on 2008-10-20, disclosed to the SEC on 2008-11-12.
Scheduled sale ($172k) by CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.80 | 500 | $9K | 5.2% |
| 2 | $17.82 | 200 | $4K | 2.1% |
| 3 | $17.83 | 200 | $4K | 2.1% |
| 4 | $17.84 | 100 | $2K | 1.0% |
| 5 | $17.85 | 1,200 | $21K | 12.5% |
| 6 | $17.86 | 300 |
| $5K |
| 3.1% |
| 7 | $17.87 | 700 | $13K | 7.3% |
| 8 | $17.88 | 900 | $16K | 9.4% |
| 9 | $17.89 | 300 | $5K | 3.1% |
| 10 | $17.90 | 600 | $11K | 6.3% |
| 11 | $19.00 | 4,334 | $82K | 48.0% |
| Total | $18.39 avg | 9,334 | $172K | 100% |
| Filing → |
| EBS | SELL | 2009-03-12 | $150K | — | Filing → |
| EBS | SELL | 2009-03-12 | $110K | — | Filing → |
| EBS | SELL | 2008-12-16 | $221K | — | Filing → |